Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in healthy toddlers: a Phase II randomized study-Reference-Cited by-同舟云学术

Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in healthy toddlers: a Phase II randomized study

Published:2020-04-01 Issue:6 Volume:16 Page:1306-1312
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Vesikari Timo¹,Borrow Ray²,Forsten Aino¹,Findlow Helen²,Dhingra Mandeep S.³^ORCID,Jordanov Emilia³

Affiliation:

1. Vaccine Research Center, University of Tampere, Tampere, Finland

2. Vaccine Evaluation Unit, Public Health England, Manchester, UK

3. Global Clinical Sciences, Sanofi Pasteur, Swiftwater, PA, USA

Funder

Sanofi Pasteur

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2020.1733869

Reference28 articles.

1. The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection

2. Neisseria meningitidis: Biology, Microbiology, and Epidemiology

3. The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004–2014

4. Meningococcal disease: changes in epidemiology and prevention

5. Global epidemiology of invasive meningococcal disease

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix in Healthy Adolescents: A Randomized Phase IIIb Multicenter Study;Infectious Diseases and Therapy;2024-07-02

2. Seamless phase 2/3 design for trials with multiple co-primary endpoints using Bayesian predictive power;BMC Medical Research Methodology;2024-01-17

3. Structured Benefit-Risk Assessment of a New Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Individuals Ages 12 Months and Older;Infectious Diseases and Therapy;2023-09-27

4. MAGLIO study: epideMiological Analysis on invasive meninGococcaL disease in Italy: fOcus on hospitalization from 2015 to 2019;Internal and Emergency Medicine;2023-08-01

5. Immunogenicity and Safety of a Quadrivalent Meningococcal Tetanus Toxoid-Conjugate Vaccine (MenACYW-TT) in Meningococcal Vaccine-Naïve Participants across a Broad Age Range (2–55 Years) in Japan: a Phase III Randomized Study;Japanese Journal of Infectious Diseases;2023-05-31